Literature DB >> 18625679

Pertussis vaccination for health care workers.

Thomas J Sandora1, Courtney A Gidengil, Grace M Lee.   

Abstract

Pertussis, an acute respiratory infection caused by Bordetella pertussis, classically manifests as a protracted cough illness. The incidence of pertussis in the United States has been increasing in recent years. Immunity wanes after childhood vaccination, leaving adolescents and adults susceptible to infection. The transmission of pertussis in health care settings has important medical and economic consequences. Acellular pertussis booster vaccines are now available for use and have been recommended for all adolescents and adults. These vaccines are safe, immunogenic, and effective. Health care workers are a priority group for vaccination because of their increased risk of acquiring infection and the potential to transmit pertussis to high-risk patients. Health care worker vaccination programs are likely to be cost-effective, but further research is needed to determine the acceptability of pertussis vaccines among health care workers, the duration of immunity after booster doses, and the impact of vaccination on the management of pertussis exposures in health care settings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625679      PMCID: PMC2493083          DOI: 10.1128/CMR.00003-08

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  92 in total

1.  Societal costs and morbidity of pertussis in adolescents and adults.

Authors:  Grace M Lee; Susan Lett; Stephanie Schauer; Charles LeBaron; Trudy V Murphy; Donna Rusinak; Tracy A Lieu
Journal:  Clin Infect Dis       Date:  2004-11-10       Impact factor: 9.079

2.  Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France.

Authors:  Alexandra Ward; Jaime Caro; Laurence Bassinet; Bruno Housset; Judith A O'Brien; Nicole Guiso
Journal:  Infect Control Hosp Epidemiol       Date:  2005-03       Impact factor: 3.254

3.  Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines.

Authors:  Tejpratap Tiwari; Trudy V Murphy; John Moran
Journal:  MMWR Recomm Rep       Date:  2005-12-09

Review 4.  Clinical and economic effects of pertussis outbreaks.

Authors:  Jeffrey P Davis
Journal:  Pediatr Infect Dis J       Date:  2005-06       Impact factor: 2.129

5.  Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers.

Authors:  Angela Calugar; Ismael R Ortega-Sánchez; Tejpratap Tiwari; Liisa Oakes; Jeffrey A Jahre; Trudy V Murphy
Journal:  Clin Infect Dis       Date:  2006-02-15       Impact factor: 9.079

6.  Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults.

Authors:  Michael E Pichichero; Margaret B Rennels; Kathryn M Edwards; Mark M Blatter; Gary S Marshall; Monica Bologa; Elaine Wang; Elaine Mills
Journal:  JAMA       Date:  2005-06-02       Impact factor: 56.272

7.  Efficacy of an acellular pertussis vaccine among adolescents and adults.

Authors:  Joel I Ward; James D Cherry; Swei-Ju Chang; Susan Partridge; Hang Lee; John Treanor; David P Greenberg; Wendy Keitel; Stephen Barenkamp; David I Bernstein; Robert Edelman; Kathryn Edwards
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

Review 8.  Pertussis sources of infection and routes of transmission in the vaccination era.

Authors:  Joop Schellekens; Carl-Heinz Wirsing von König; Pierce Gardner
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

9.  Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Authors:  Kristine M Bisgard; Philip Rhodes; Beverly L Connelly; Daoling Bi; Christine Hahn; Sarah Patrick; Mary P Glodé; Kristen R Ehresmann
Journal:  Pediatrics       Date:  2005-08       Impact factor: 7.124

10.  How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

Authors:  Scott A Halperin; Lamont Sweet; Darlene Baxendale; Anne Neatby; Petra Rykers; Bruce Smith; Mitchell Zelman; Diane Maus; Pierre Lavigne; Michael D Decker
Journal:  Pediatr Infect Dis J       Date:  2006-03       Impact factor: 2.129

View more
  12 in total

1.  Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine.

Authors:  M Riffelmann; M Littmann; C Hülsse; C H Wirsing von König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-17       Impact factor: 3.267

2.  Factors affecting uptake of recommended immunizations among health care workers in South Australia.

Authors:  Jane L Tuckerman; Joanne E Collins; Helen S Marshall
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Health care workers and pertussis: an underestimated issue.

Authors:  Sabine Wicker; Markus A Rose
Journal:  Med Klin (Munich)       Date:  2011-01-16

Review 4.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

5.  Tetanus, diphtheria and acellular pertussis (Tdap) vaccination among healthcare personnel-United States, 2011.

Authors:  Peng-jun Lu; Samuel B Graitcer; Alissa O'Halloran; Jennifer L Liang
Journal:  Vaccine       Date:  2013-12-03       Impact factor: 3.641

6.  Tdap Vaccination Among Healthcare Personnel-21 States, 2013.

Authors:  Alissa C O'Halloran; Peng-Jun Lu; Sarah A Meyer; Walter W Williams; Pamela K Schumacher; Aaron L Sussell; Jan E Birdsey; Winifred L Boal; Marie Haring Sweeney; Sara E Luckhaupt; Carla L Black; Tammy A Santibanez
Journal:  Am J Prev Med       Date:  2017-11-21       Impact factor: 5.043

7.  Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.

Authors:  Peng-Jun Lu; Mei-Chuan Hung; Anup Srivastav; Lisa A Grohskopf; Miwako Kobayashi; Aaron M Harris; Kathleen L Dooling; Lauri E Markowitz; Alfonso Rodriguez-Lainz; Walter W Williams
Journal:  MMWR Surveill Summ       Date:  2021-05-14

8.  Modelling the return on investment of preventively vaccinating healthcare workers against pertussis.

Authors:  Luqman Tariq; Marie-Josée J Mangen; Anke Hövels; Gerard Frijstein; Hero de Boer
Journal:  BMC Infect Dis       Date:  2015-02-19       Impact factor: 3.090

9.  Isolation of High Level Macrolide Resistant Bordetella pertussis Without Transition Mutation at Domain V in Iran.

Authors:  Bahman Mirzaei; Zakaria Bameri; Ryhane Babaei; Fereshteh Shahcheraghi
Journal:  Jundishapur J Microbiol       Date:  2015-07-25       Impact factor: 0.747

10.  Does working in hospital increases seroprevalence and carrier state against Bordetella pertussis?

Authors:  Alireza Emami Naeini; Nasim Zaman; Farzin Khorvash; Sahar Emami Naeini; Hesam-Al-Din Khodadadi; Mojgan Mokhtari; Ali Mehrabi Koushki
Journal:  Adv Biomed Res       Date:  2015-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.